切换导航
关闭
  • 菜单
  • Setting

Pemetrexed

培美曲塞二钠盐
Catalog No.
A4390
TS、DHFR、GARFT和AICARFT抑制剂
组合的产品项目
规格价格库存 数量
10mM (in 1mL DMSO)
¥ 454.00
现货
100mg
¥ 454.00
现货
200mg
¥ 727.00
现货

电话: 021-55669583

邮箱: sales@apexbio.cn

全球经销商

A

背景

Pemetrexed(也称为pemetrexed disodium)是一种新型的抗叶酸抗代谢物,它可以作用于涉及嘌呤和嘧啶合成的多种酶。Pemetrexed是抗叶酸物GARFYT抑制剂lometroxol的类似物,和lometroxol具有相似的化学结构。叶酸的pterine部分的吡嗪环和桥部分的苄基分别被吡咯环和亚甲基得到lometroxol。Pemetrexed对TS、DHFR、GARFT和AICARFT抑制性很强,但是在一系列的肿瘤,包括非小细胞肺癌、恶性间皮瘤、乳房癌、结直肠癌、子宫颈癌、头部和颈部和膀胱中抑制活性较弱。

参考文献:
[1].  Luis Paz-Ares, Susana Bezares, Jose M. Tabernero, Daniel Castellanos, and Hernan Cortes-Funes. Review of a promising new agent-pemetrexed disodium. Cancer 2003; 97(8 Suppl):2056-2063.

文献引用

化学属性

Physical AppearanceA solid
StorageStore at -20°C
M.Wt471.37
Cas No.150399-23-8
FormulaC20H19N5Na2O6
SynonymsPemetrexed disodium, LY-231514, Pemetrexed Na
Solubilityinsoluble in EtOH; ≥15.68 mg/mL in DMSO with gentle warming and ultrasonic; ≥30.67 mg/mL in H2O
Chemical Namedisodium;(2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
SDFDownload SDF
Canonical SMILESC1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+]
运输条件 蓝冰运输或根据您的需求运输。
一般建议不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。

试验操作

Cell experiment:[1]

Cell lines

Human tumor cell lines, including CCRF-CEM leukemia, GC3/C1 colon carcinoma, and HCT-8 ileocecal carcinoma

Reaction Conditions

0.0001 ~ 30 μM pemetrexed for 72 h incubation

Applications

Pemetrexed exerted antiproliferative activity in all three cell lines. Thymidine (5 μM) only increased the IC50 of pemetrexed versus CCRF-CEM cells by 5.5-fold, GC3/C1 by 18.7-fold, and HCT-8 by 15-fold. Higher drug concentrations of pemetrexed required the combination of thymidine and hypoxanthine to protect these cells.

Animal experiment:[2]

Animal models

An intrathoracic murine model of malignant mesothelioma

Dosage form

100 mg/kg

Administered intraperitoneally from days 4 ~ 8

Applications

The combination of pemetrexed and regulatory T cell (Treg) blockade showed synergistic antitumor effects in murine malignant mesothelioma, resulting in prolonged survival. This combination was associated with decreased tumor-infiltrating Tregs, increased IL-2 production, dendritic cell maturation, and increased CD3+CD8+IFN-γ+ tumor-infiltrating T cells when compared with mice treated with pemetrexed alone or Treg blockade alone.

Note

The technical data provided above is for reference only.

References:

1. Shih C, Chen VJ, Gossett LS, et al. LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. Cancer Research, 1997, 57(6): 1116-1123.

2. Anraku M, Tagawa T, Wu L, et al. Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma. Journal of Immunology, 2010, 185(2):956-966.

生物活性

描述 Pemetrexed是TS(Ki = 1.3 nM)、DHFR(Ki = 7.2 nM)和GARFT(Ki = 65 nM)的一种新型的抗叶酸物抗代谢物。
靶点 TS DHFR GARFT      
IC50 1.3 nM (Ki) 7.2 nM (Ki) 65 nM (Ki)      

质量控制